MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


DCC to return £800 million from Healthcare sale as pivots to Energy

ALN

DCC PLC on Tuesday announced plans to return £800 million to shareholders as it pushes ahead with plans to focus on its Energy business.

The news came as the Dublin-based sales, marketing, and support services provider said pretax profit fell 18% to £294.9 million in the year to March 31 from £359.2 million a year prior. Diluted earnings per share declined 37% to 208.44 pence from 329.85p.

Revenue fell 4.4% to £18.01 billion from £18.85 billion due to lower revenue in DCC Energy where average commodity prices were lower.

Revenue in DCC Energy fell 6.0% to £13.4 billion while sales in DCC Technology increased 0.3% to £4.6 billion, mainly driven by revenue growth in Pro Tech.

Adjusted operating profit from continuing operations increased 3.0% to £703.6 million from £682.8 million a year prior, below £713 million consensus, cited by RBC Capital Markets.

Last November, DCC announced the sale of DCC Healthcare for an enterprise value of £1.05 billion.

On Monday, DCC said it plans to return £800 million of proceeds to shareholders.

This will comprise a £100 million share buyback, which will begin shortly, a £600 million return on completion of the deal, and a further £100 million following receipt of deferred consideration in around two years.

The deal is expected to close in the third quarter of 2025.

Chief Executive Donal Murphy said: ‘Our sale of DCC Healthcare enables a material return of capital to shareholders. We will focus our efforts on Energy, our largest and highest-returning business. We are energised about the future.’

Free cash flow declined to £588.8 million from £681.1 million and return on capital employed fell to 15.3% from 15.5%.

The dividend was increased by 5.0% to 206.40p from 196.57p.

Looking ahead, DCC said it expects the year to March 31 2026 will be a year of ‘good operating profit growth on a continuing basis, strategic progress and continued development activity.’

Shares in DCC were down 3.2% at 4,909.24 pence on Tuesday morning in London. The wider FTSE 100 index was up 0.1%.

Copyright 2025 Alliance News Ltd. All Rights Reserved.